01 January 1970 0 414 Report

Let's imagine that we have a patient with migraine with frequent attacks which is successfully treated with monoclonal antibodies against CGRP. However this patient is not a super responder and still have migraine attacks. What do You recommend for him/her to treat her/his attacks: gepant (similar mechanism of action to mAbs) or triptans (antother mechanism of action) ? Is gepants a good option if the patient has a contraindications to triptans ?

More Marcin Kopka's questions See All
Similar questions and discussions